Editorial: non-alcoholic fatty liver disease-a pandemic in need of novel treatments and endpoints
Aliment Pharmacol Ther
.
2017 Jul;46(1):65-66.
doi: 10.1111/apt.14081.
Authors
V Ajmera
1
,
R Loomba
2
Affiliations
1
Division of Gastroenterology, University of California, San Francisco, San Francisco, CA, USA.
2
Division of Gastroenterology, NAFLD Research Center, University of California, San Diego, La Jolla, CA, USA.
PMID:
28589576
PMCID:
PMC5501982
DOI:
10.1111/apt.14081
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Fatty Liver
Humans
Non-alcoholic Fatty Liver Disease*
Pandemics*
Grants and funding
R01 DK106419/DK/NIDDK NIH HHS/United States